Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder
NCT ID: NCT00628979
Last Updated: 2009-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2008-03-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exposure Therapy For Veterans With PTSD And Panic Attacks
NCT01033136
Transdiagnostic Cognitive Behavioral Treatment for Anxiety
NCT03810456
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
NCT01947647
Comparing Individual Therapies for Veterans With Depression, PTSD, and Panic Disorder
NCT04293341
A Pragmatic Trial of Brief CBT for Anxiety in VA Primary Care
NCT04523779
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
CBT
CBT
cognitive- behavioral treatment for panic disorder.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT
cognitive- behavioral treatment for panic disorder.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. age 18-74;
3. current diagnosis of panic disorder;
4. PTSD symptoms that either meet full diagnostic criteria from the Diagnostic and Statistical Manual-Fourth Edition (DSM-IV) or are at a sub-clinical level. Sub-clinical PTSD is defined as patients who meet either PTSD criteria B and C or B and D, but fail to meet all three;
5. panic disorder and PTSD present for at least 1 month;
6. PART 1 only: patients who are clinically eligible to participate in the study and refuse standard psychosocial treatments (e.g., 12 weeks of cognitive behavioral therapy) for panic disorder.
Exclusion Criteria
2. diagnosed with bipolar disorder or psychosis;
3. current suicidal/homicidal ideation and intent;
4. severe depression (precluding participation in a research study);
5. panic attacks related only to a diagnosis of a specific phobia;
6. medical conditions mimicing anxiety (e.g., mitral valve prolapse);
7. PART 1 only: patients who are clinically eligible for the study and are willing to engage in a minimum of 12 weeks of psychosocial treatment for panic disorder.
18 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Veterans Affairs
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Teng, PhD
Role: PRINCIPAL_INVESTIGATOR
Michael E. DeBakey VA Medical Center (152)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael E. DeBakey VA Medical Center (152)
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIRECC004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.